Erin Hunter, Assistant Editor

Interventions targeting respiratory viruses should be considered as a means of protecting against invasive pneumococcal disease in children, study finds.

A patient’s neurological symptoms diminished when he discontinued a biosimilar and started various new treatments.

Sodium oxybate is currently being studied for long-term safety and tolerability in the open label RESTORE clinical study in adults with narcolepsy.

Investigators noted medication prescription disparities among patients with dementia despite factoring for age and sex.

The partnership to deliver HIV medications will reduce transportation and access barriers for patients, especially in underserved communities.

The 10 mL ready-to-administer pre-filled syringe in the first FDA-approved pre-filled syringe in this dosing size.

Vitamin D may reduce the risk of dementia because it clears amyloid that accumulates in the brain.

Pembrolizumab showed statistically significant improvement in the event-free survival of patients with resectable stage 2 or 3 non-small cell lung cancer.

The FDA set a Prescription Drug User Fee Act for May 2023 for Pfizer’s respiratory syncytial virus bivalent vaccine candidate.

Clinical guidelines suggest screening for cardiovascular risk factors post-partum in women, however, these recommendations are not closely followed, a new study suggests.

The set of principles seeks to improve publication patterns to show the value of the pharmacist and how journals can strengthen pharmacy practice as a scientific discipline.

Aflibercept injection (8 mg) in a 12-week dosing regimen was found non inferior in vision gains compared to 8-week dosing regimen with 2 mg.

Virologic suppression was similar between the long-acting and once-daily treatments for HIV, but participants were more satisfied with the former.

Lenacapavir, combined with broadly neutralizing HIV antibodies, found effective at viral suppression in patients with HIV.

Cognitive performance was higher if a person maintained physical activity throughout their lifetime.

Increasing interventions for affordable housing and food security could contribute to reduced rates of heart disease in lower income communities.

In a subgroup analysis, patients with COVID-19 who received conventional oxygen support also benefitted, having 20 fewer deaths per 1000 patients when given remdesivir.

Sparsentan decreased proteinuria by nearly 50% in patients with IgA nephropathy, which may slow kidney function decline.

Positive data on the novel prostate cancer combination treatment was presented at the 2023 American Society of Clinical Oncology Genitourinary Cancers Symposium.

Current treatment options for depression lead to discontinuation because they are slower to work and have worse adverse event profiles.

Artificial intelligence is allowing researchers to redesign the interaction between the immune system and the protein of an allergen to safely overcome symptoms.

Olaparib with abiraterone increased survival in patients with metastatic prostate cancer compared to the current standard of care, according to a session at the ASCO Genitourinary Cancers Symposium.

One of the major concerns about getting a flu vaccine is its safety for women during pregnancy.

Letermovir is the only drug approved for prophylaxis of cytomegalovirus (CMV) infection for patients who are CMV-seropositive and have received an allogeneic HSCT.

Incidence of regional tumor recurrence in patients with HR–positive breast cancer did not significantly differ between patients who received post operational radiotherapy.

Antibodies from an original COVID-19 vaccination may treat the mRNA booster vaccine as a virus that needs to be cleared.

The risk of new-onset cardiometabolic diseases was significantly elevated post-COVID-19 infection compared to pre-COVID-19 infection.

Health care providers prescribe naloxone to 1 in every 70 patients prescribed a high-dose opioid medication.

Arrhythmia was found to be the most common cardiovascular complication of COVID-19.

Patients with heart failure are at a significant risk of cardiorenal diseases, highlighting the need for improved treatments and cost management.